Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8110
+0.0510 (6.71%)
Apr 2, 2025, 4:00 PM EDT - Market closed

Estrella Immunopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
293819--
Market Cap Growth
11.11%101.23%---
Enterprise Value
283321--
Last Close Price
0.761.0510.8410.00-
PB Ratio
191.398.94-2.81--
P/TBV Ratio
302.068.94---
Debt / Equity Ratio
-0.000.00--
Quick Ratio
0.3123.050.254.32-
Current Ratio
0.5524.650.285.20-
Return on Assets (ROA)
--122.12%-174.75%--
Earnings Yield
-30.19%-19.14%-58.56%--
Buyback Yield / Dilution
-255.55%-8764.81%---
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q